Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Crigler-Najjar Syndrome - Pipeline Review, H2 2017 - Research and Markets

Research and Markets
Posted on: 29 Aug 17

The "Crigler-Najjar Syndrome - Pipeline Review, H2 2017" report has been added to Research and Markets' offering.

Crigler-Najjar Syndrome - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Crigler-Najjar Syndrome (Genetic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Crigler-Najjar Syndrome (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Crigler-Najjar Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, IND/CTA Filed and Preclinical stages are 1, 1 and 4 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.

Key Topics Covered:

  1. Crigler-Najjar Syndrome - Overview
  2. Crigler-Najjar Syndrome - Therapeutics Development
  3. Pipeline Overview
  4. Pipeline by Companies
  5. Pipeline by Universities/Institutes
  6. Products under Development by Companies
  7. Products under Development by Universities/Institutes
  8. Crigler-Najjar Syndrome - Therapeutics Assessment
  9. Assessment by Target
  10. Assessment by Mechanism of Action
  11. Assessment by Route of Administration
  12. Assessment by Molecule Type
  13. Crigler-Najjar Syndrome - Companies Involved in Therapeutics Development
  • Audentes Therapeutics Inc
  • Genethon SA
  • International Stem Cell Corp
  • Promethera Biosciences SA

For more information about this report visit https://www.researchandmarkets.com/research/zn65ng/criglernajjar

View source version on businesswire.com: http://www.businesswire.com/news/home/20170829005616/en/

Business Wire
www.businesswire.com

Last updated on: 29/08/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.